Literature DB >> 24891176

Thyroid disease and cognition.

Mary H Samuels1.   

Abstract

Overt hypothyroidism and thyrotoxicosis are associated with significant decrements in mood and cognitive function, and therapy usually leads to improvement in these symptoms. In contrast, major affective or cognitive dysfunction is not typical of subclinical thyroid disease. Subtle deficits in specific cognitive domains (primarily working memory and executive function) likely exist in subclinical hypothyroidism and thyrotoxicosis, but these are unlikely to cause major problems in most patients. Patients with mild thyroid disease and significant distress related to mood or cognition most likely have independent diagnoses that should be evaluated and treated separately.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognition; Hypothyroidism; Mood; Subclinical hypothyroidism; Subclinical thyrotoxicosis; Thyrotoxicosis

Mesh:

Year:  2014        PMID: 24891176     DOI: 10.1016/j.ecl.2014.02.006

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  15 in total

Review 1.  Targeting Hormones for Improving Cognition in Major Mood Disorders and Schizophrenia: Thyroid Hormones and Prolactin.

Authors:  Meritxell Tost; José Antonio Monreal; Antonio Armario; Juan David Barbero; Jesús Cobo; Clemente García-Rizo; Miquel Bioque; Judith Usall; Elena Huerta-Ramos; Virginia Soria; Javier Labad
Journal:  Clin Drug Investig       Date:  2020-01       Impact factor: 2.859

Review 2.  Psychiatric and cognitive manifestations of hypothyroidism.

Authors:  Mary H Samuels
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

3.  Thyroid Function Variations Within the Reference Range Do Not Affect Quality of Life, Mood, or Cognitive Function in Community-Dwelling Older Men.

Authors:  Mary H Samuels; Rajani Kaimal; Avantika Waring; Howard A Fink; Kristine Yaffe; Andrew R Hoffman; Eric Orwoll; Douglas Bauer
Journal:  Thyroid       Date:  2016-09       Impact factor: 6.568

4.  Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments.

Authors:  G Grani; D Tumino; V Ramundo; L Ciotti; C Lomonaco; M Armillotta; R Falcone; P Lucia; M Maranghi; S Filetti; C Durante
Journal:  J Endocrinol Invest       Date:  2019-06-15       Impact factor: 4.256

Review 5.  Individualized Therapy for Hypothyroidism: Is T4 Enough for Everyone?

Authors:  Matthew D Ettleson; Antonio C Bianco
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

6.  Thyroid hormones are associated with longitudinal cognitive change in an urban adult population.

Authors:  May A Beydoun; Hind A Beydoun; Ola S Rostant; Greg A Dore; Marie T Fanelli-Kuczmarski; Michele K Evans; Alan B Zonderman
Journal:  Neurobiol Aging       Date:  2015-08-08       Impact factor: 4.673

7.  Effect of Thyroid Function Variations Within the Laboratory Reference Range on Health Status, Mood, and Cognition in Levothyroxine-Treated Subjects.

Authors:  Mary H Samuels; Irina Kolobova; Anne Smeraglio; Meike Niederhausen; Jeri S Janowsky; Kathryn G Schuff
Journal:  Thyroid       Date:  2016-07-25       Impact factor: 6.568

Review 8.  The relation between thyroid dysregulation and impaired cognition/behaviour: An integrative review.

Authors:  Manizhe Eslami-Amirabadi; Seyed Ahmad Sajjadi
Journal:  J Neuroendocrinol       Date:  2021-03       Impact factor: 3.627

9.  Aerobic physical exercise improved the cognitive function of elderly males but did not modify their blood homocysteine levels.

Authors:  Hanna Karen M Antunes; Marco Túlio De Mello; Valdir de Aquino Lemos; Ruth Ferreira Santos-Galduróz; Luciano Camargo Galdieri; Orlando Francisco Amodeo Bueno; Sergio Tufik; Vânia D'Almeida
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2015-01-21

10.  Effect of Mild Thyrotoxicosis on Performance and Brain Activations in a Working Memory Task.

Authors:  Anna Göbel; Marcus Heldmann; Martin Göttlich; Anna-Luise Dirk; Georg Brabant; Thomas F Münte
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.